COVID-19 mRNA vaccines do not contain the SV40 virus. What they do contain, in trace amounts, is a small segment of DNA called the SV40 promoter/enhancer sequence, which is part of the manufacturing template used to produce the vaccines. This distinction matters: the SV40 promoter is a common tool in molecular biology, not the virus itself, and the residual DNA left behind in the final product has been measured well below safety limits set by regulators worldwide.
What Was Actually Found
The concern traces back to researchers who examined Pfizer’s Comirnaty vaccine and reported finding DNA sequences that include an SV40 promoter/enhancer region. This finding is real but requires context. The SV40 promoter is a short stretch of DNA (roughly 372 base pairs) borrowed from Simian Virus 40 decades ago. It has been a standard component in laboratory plasmids, the circular DNA templates used across biotechnology to produce everything from insulin to gene therapies. Pfizer used a plasmid containing this sequence as the template for manufacturing its mRNA.
During production, the plasmid serves as a blueprint. Enzymes read the plasmid and transcribe it into the mRNA that becomes the active ingredient in the vaccine. Once that transcription is complete, the plasmid DNA is no longer needed. Manufacturers then use enzymes called DNases to chop up and remove the template DNA, followed by additional purification steps to filter out the fragments. The process is effective but not perfect: very small fragments of plasmid DNA, including pieces of the SV40 promoter region, can remain in the final product.
How Much Residual DNA Is in the Vaccine
A 2025 study published in npj Vaccines (a Nature Portfolio journal) analyzed 15 batches of both Comirnaty and Spikevax using four independent laboratory methods. The results showed that residual DNA in every batch fell below approved regulatory limits. Those fragments consisted of small, degraded pieces originating from the manufacturing template.
The World Health Organization sets the acceptable threshold for residual DNA at 10 nanograms per vaccine dose. That limit has been in place since 1996, and it applies broadly to vaccines produced using cell-based or DNA-template methods. The European Medicines Agency has confirmed that no batch of mRNA vaccine released in the EU exceeded this threshold. The EMA has also stated it has seen no evidence linking residual DNA to side effects.
Why the SV40 Promoter Is Not the SV40 Virus
SV40, or Simian Virus 40, is a DNA virus that was discovered in the 1960s as a contaminant in early polio vaccines grown in monkey kidney cells. That history understandably makes the name alarming. But the SV40 promoter used in modern plasmids is just a short regulatory sequence, a snippet of genetic code that helps DNA function efficiently inside lab-grown cells. It cannot produce viral proteins, replicate, or cause infection. It is to the SV40 virus roughly what a single sentence is to an entire book.
This promoter sequence has been used in molecular biology for decades precisely because it works well as a genetic “on switch” in laboratory settings. Its presence in the manufacturing plasmid reflects standard biotech practice, not a safety oversight.
Could Residual DNA Change Your Genes
The most serious version of this concern is whether leftover DNA fragments could integrate into your genome and cause cancer or other harm. Multiple biological barriers make this scenario extremely unlikely.
- mRNA vaccines deliver their payload to the cytoplasm, the outer compartment of your cells. They are not designed to enter the nucleus, where your chromosomes are stored.
- Foreign DNA in the cytoplasm gets destroyed. Your cells contain enzymes specifically tasked with breaking down stray DNA that appears where it shouldn’t be.
- Getting into the nucleus requires passing through selective gates in the nuclear membrane. Small, degraded DNA fragments lack the molecular signals needed to gain entry.
- Integration into your chromosomes requires specialized enzymes called integrases, which are not present in mRNA vaccines. Without them, a DNA fragment cannot splice itself into your genome.
- Even random integration rarely does anything functional. A fragment would need to land in exactly the right spot and be in the right orientation to affect gene expression, which is vanishingly improbable.
In short, residual DNA fragments would need to survive degradation in the cytoplasm, cross the nuclear membrane, integrate without the necessary enzymes, and land in a functionally relevant location. Each step is independently unlikely, and together they represent a chain of events that scientists describe as biologically implausible.
What Regulators Have Concluded
The EMA, which oversees drug safety for the European Union, has explicitly addressed this issue. It confirms that the manufacturing process includes dedicated steps to break down and remove plasmid DNA, that residual levels are monitored and fall within acceptable limits, and that no safety signal has emerged from the trace amounts present. The WHO’s longstanding 10-nanogram-per-dose limit was established through risk modeling that accounts for worst-case scenarios, including the theoretical presence of DNA from infected cell lines, and builds in a safety factor of 60 even before accounting for the enzymatic digestion and purification that mRNA vaccines undergo.
The manufacturing process itself uses multiple layers of cleanup. DNase enzymes are added to the product after mRNA transcription is complete, incubated to allow thorough digestion of the DNA template, and then followed by size-based separation methods that filter out the resulting small fragments. Some manufacturers use DNase attached to solid supports, which makes removal of both the enzyme and the DNA debris more efficient.
The Bottom Line on SV40 and COVID Vaccines
The vaccines contain trace fragments of a manufacturing template that happens to include an SV40 promoter sequence. They do not contain the SV40 virus. The residual DNA is present in amounts below internationally established safety thresholds, consists of small degraded fragments rather than intact functional sequences, and faces multiple biological barriers that prevent it from affecting your cells’ genetic material. Regulatory agencies in both Europe and globally have reviewed the data and found no evidence of harm from these residual traces.